Item 6B
approved amendmentAug 28, 2019
Description
Authorize to amend item #21, originally approved by G&C on July 31, 2019, which requested authorization to: 1)accept and expend $7,200,000 of federal funds; 2)contingent upon #1, transfer $7,200,000 of general funds; 3)contingent upon #2, accept and expend $165,285 of additional federal funds; 4)contingent upon #2, accept and expend $3,177,972 of additional federal funds; and 5)contingent upon #2 accept and expend $1,178,678 of federal funds, by extending such authority on a pro-rate basis from August 31, 2019 through September 30, 2019. Contingent upon Fiscal Committee approval on August 28, 2019.
Amount
$7.2M
$7,200,000, $7,200,000, $165,285, $3,177,972, $1,178,678
Effective Dates
August 31, 2019 — September 30, 2019
Vote Record
approved
Motion by Volinsky, seconded by Prescott
Michael Cryans
(D)
yes
Andru Volinsky
(D)
yes
Russell Prescott
(R)
yes
Ted Gatsas
(R)
yes
Debora Pignatelli
(D)
yes
Related Sub-Items (4)
6
Authorize to exceed the 3/12 limitation in the amount of $5,001,333. Effective upon G&C approval through September 30, 2019. 44% General, 56% Other Funds. Contingent upon Fiscal Committee approval on
$5.0M
approved
6A
Authorize to retroactively continue on full-time temporary Program Specialist II position, salary grade 21. Effective July 1, 2019 through June 30, 2020. 64% Federal, 36% General Funds.
approved
6C
Authorize to accept and expend additional agency income drug rebate revenue in the amount of $2,000,000. Effective upon G&C approval through September 30, 2019. 100% Other Funds (Drug Rebate Revenue).
$2.0M
approved
6D
Authorize to amend item #20A, originally approved by G&C on July 31, 2019, which requested authorization to: 1)exceed the 3/12 limitation in the amount of $7,951,274; and 2)accept federal funds in the
$8.0M
approved
Documents (5)
Item_6.pdf
Open in new tab →
Item_6A.pdf
(6A)
Open in new tab →
Item_6B.pdf
(6B)
Open in new tab →
Item_6C.pdf
(6C)
Open in new tab →
Item_6D.pdf
(6D)
Open in new tab →